Dare Bioscience Inc (DARE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Operating Expenses | 3,625 | 7,677 | 9,139 | 1,333 | 480 |
| Operating Income | -3,625 | -7,677 | -9,139 | -1,333 | -480 |
| Other Income | 43 | 12 | 8 | -296 | -19 |
| Pre-tax Income | -3,582 | -7,666 | -9,131 | -1,630 | -498 |
| Net Income Continuous | -3,582 | -7,666 | -9,131 | -1,630 | -498 |
| Net Income | $-3,582 | $-7,666 | $-9,131 | $-1,630 | $-498 |
| EPS Basic Total Ops | -3.84 | -10.56 | -28.93 | -3.96 | -6.60 |
| EPS Basic Continuous Ops | -3.76 | -10.60 | -29.01 | -3.92 | -6.57 |
| EPS Diluted Total Ops | -3.84 | -10.56 | -28.93 | -3.96 | -6.60 |
| EPS Diluted Continuous Ops | -3.76 | -10.60 | -29.01 | -3.92 | -6.57 |
| EBITDA(a) | $-3,625 | $-2,490 | $-9,139 | $-1,333 | $-480 |